Puma Biotechnology(PBYI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBYI Puma Biotechnology

Not Yet Opened 04-01 16:00:00 EDT

6.76

+0.37

+5.79%

盘后6.72

-0.04-0.59%

19:05 EDT

High6.85	Low6.46	Vol368.00K
Open6.47	D1 Closing6.39	Amplitude6.18%
Mkt Cap343.93M	Tradable Cap260.68M	Total Shares50.88M
T/O2.47M	T/O Rate0.95%	Tradable Shares38.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PBYI","market":"US","secType":"STK","nameCN":"Puma Biotechnology","latestPrice":6.76,"timestamp":1775073600000,"preClose":6.39,"halted":0,"volume":367999,"hourTrading":{"tag":"盘后","latestPrice":6.72,"preClose":6.76,"latestTime":"19:05 EDT","volume":9466,"amount":63984.545,"timestamp":1775084750359,"change":-0.04,"changeRate":-0.005917,"amplitude":0.005917},"delay":0,"changeRate":0.05790297339593116,"floatShares":38562636,"shares":50876487,"eps":0.61,"marketStatus":"Not Yet Opened","change":0.37,"latestTime":"04-01 16:00:00 EDT","open":6.47,"high":6.85,"low":6.455,"amount":2471591.1685014,"amplitude":0.061815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.61,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775116800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1332302400000,"exchange":"NASDAQ","adjPreClose":6.39,"preHourTrading":{"tag":"盘前","latestPrice":6.39,"preClose":6.39,"latestTime":"08:55 EDT","volume":128,"amount":828.84992,"timestamp":1775048130572,"change":0,"changeRate":0,"amplitude":0.015649},"postHourTrading":{"tag":"盘后","latestPrice":6.72,"preClose":6.76,"latestTime":"19:05 EDT","volume":9466,"amount":63984.545,"timestamp":1775084750359,"change":-0.04,"changeRate":-0.005917,"amplitude":0.005917},"volumeRatio":1.739732,"impliedVol":0.601,"impliedVolPercentile":0.1155},"requestUrl":"/m/hq/s/PBYI/wiki","defaultTab":"wiki","newsList":[{"id":"2614888205","title":"Analysts Are Neutral on Top Healthcare Stocks: Puma Biotechnology (PBYI), Cytek Biosciences (CTKB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614888205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614888205?lang=en_us&edition=fundamental","pubTime":"2026-02-27 12:50","pubTimestamp":1772167811,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Puma Biotechnology (PBYI – Research Report) and Cytek Biosciences (CTKB – Research Report) with neutr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-neutral-on-top-healthcare-stocks-puma-biotechnology-pbyi-cytek-biosciences-ctkb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-neutral-on-top-healthcare-stocks-puma-biotechnology-pbyi-cytek-biosciences-ctkb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTKB","HCSG","PBYI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614074624","title":"Puma Biotechnology sees Q1 revenue $38M-$42M, one estimate $49M","url":"https://stock-news.laohu8.com/highlight/detail?id=2614074624","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614074624?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:59","pubTimestamp":1772143147,"startTime":"0","endTime":"0","summary":"Sees FY26 revenue $214M-$221M, one estimates $220M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/puma-biotechnology-sees-q1-revenue-38m-42m-one-estimate-49m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/puma-biotechnology-sees-q1-revenue-38m-42m-one-estimate-49m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614027075","title":"Puma Biotechnology Q4 Adj. EPS $0.30 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614027075","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614027075?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:06","pubTimestamp":1772139965,"startTime":"0","endTime":"0","summary":"Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.23 by 32.16 percent. This is a 30.23 percent decrease over earnings of $0.43 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50909241/puma-biotechnology-q4-adj-eps-0-30-beats-0-23-estimate-sales-75-500m-beat-68-600m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Puma Biotechnology Q4 Adj. EPS $0.30 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614076373","title":"BRIEF-Puma Biotechnology Q4 Adjusted EPS USD 0.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2614076373","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614076373?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:05","pubTimestamp":1772139947,"startTime":"0","endTime":"0","summary":"BRIEF-Puma Biotechnology Q4 Adjusted EPS USD 0.3\n\n\nFeb 26 (Reuters) - Puma Biotechnology Q4 product revenue USD 59.9 million.\n\nQ4 net income USD 13.4 million\nQ4 EPS USD 0.27\nQ4 adjusted net income USD 15.1 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLXE9D1E0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614079952","title":"Puma Biotechnology Outlook FY Revenue USD 214-221 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614079952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614079952?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:05","pubTimestamp":1772139902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLXE9D1E0:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614074856","title":"Puma Biotechnology Inc Outlook FY26 Total REV $214–$221 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614074856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614074856?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:05","pubTimestamp":1772139902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLXE9D1E0:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614725996","title":"Puma Biotechnology Inc  expected to post earnings of 23 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2614725996","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614725996?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:50","pubTimestamp":1771969806,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc  expected to post earnings of23cents a share - Earnings Preview Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to  show a rise in quarterly revenue when it reports  results o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL8N3ZK2VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613700737","title":"Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613700737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613700737?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:15","pubTimestamp":1771881326,"startTime":"0","endTime":"0","summary":"Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference               Puma Biotechnology Inc. said its CEO Alan H. Auerbach will present an overview of the company at TD Cowen’s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL28ZKw9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611547970","title":"Puma Biotechnology Inc. to Host Conference Call on Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2611547970","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611547970?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:10","pubTimestamp":1770930626,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will host a conference call to discuss the results at 1:30 p.m. PT/4:30 p.m. ET. The call and presentation slides will be available via a live webcast in the Investors section of the Puma Biotechnology website. A replay will be archived on the website for 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on February 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL95zHZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609311417","title":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2609311417","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609311417?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:58","pubTimestamp":1770245936,"startTime":"0","endTime":"0","summary":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing RuleFeb 4 (Reuters) - Puma Biotechnology Inc PBYI.O:PUMA BIOTECHNOLOGY REPORTS INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA6MCKDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609333319","title":"Puma Biotechnology Grants Inducement Stock Awards to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2609333319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609333319?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:05","pubTimestamp":1770242711,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. announced the grant of inducement restricted stock unit awards covering 14,750 shares of common stock to two new non-executive employees. These awards vest over a three-year period, with one-third vesting on the first anniversary of the vesting commencement date, February 1, 2026, and one-sixth vesting on each six-month anniversary thereafter, subject to continued service.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL50FdVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609319887","title":"Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319887?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:05","pubTimestamp":1770242700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA6MCKDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608879115","title":"Rigel Pharmaceuticals beruft Michael P. Miller in den Vorstand","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879115","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879115?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:05","pubTimestamp":1770123921,"startTime":"0","endTime":"0","summary":"Rigel Pharmaceuticals Inc. hat die Ernennung von Michael P. Miller in den Vorstand bekannt gegeben. Miller verfügt über mehr als vierzig Jahre Erfahrung in kommerziellen und leitenden Positionen in der Biotechnologie- und Pharmaindustrie und ist derzeit auch in den Vorstnden von Puma Biotechnology und BioXcel Therapeutics ttig.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rigel Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL8rsG3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","RIGL","BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602231212","title":"Puma Biotechnology CFO Maximo Nougues Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602231212","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602231212?lang=en_us&edition=fundamental","pubTime":"2026-01-09 09:15","pubTimestamp":1767921328,"startTime":"0","endTime":"0","summary":"Maximo F. Nougues, Chief Financial Officer of Puma Biotechnology Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL8c00Jw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Puma Biotechnology CFO Maximo Nougues Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601384435","title":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601384435","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601384435?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:28","pubTimestamp":1767824902,"startTime":"0","endTime":"0","summary":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)Jan 8 (Reuters) - Puma Biotechnology Inc PBYI.O:PUMA BIOTECHNOLOGY REPORTS INDUCEMENT AWARDS UNDER NASDAQ LISTING","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUAKCDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601563384","title":"Puma Biotechnology Grants Inducement Stock Awards to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2601563384","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601563384?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:15","pubTimestamp":1767824114,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. announced that its Compensation Committee approved inducement restricted stock unit awards covering 10,500 shares of Puma common stock to three new non-executive employees. The awards will vest over a three-year period, with one-third vesting on January 1, 2026, and the remaining shares vesting in equal portions every six months thereafter, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL96lP7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593273472","title":"US Market's Undiscovered Gems to Explore This December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2593273472","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593273472?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:03","pubTimestamp":1766574188,"startTime":"0","endTime":"0","summary":"As the U.S. stock market continues to reach new heights, with the S&P 500 closing at a record high after a series of positive economic indicators, investors are keenly observing the landscape for promising opportunities. In this vibrant market environment, identifying undiscovered gems among small-cap stocks can offer unique growth potential, especially as these companies often thrive in periods of robust economic expansion and increased consumer spending.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pbyi/puma-biotechnology/news/us-markets-undiscovered-gems-to-explore-this-december-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pbyi/puma-biotechnology/news/us-markets-undiscovered-gems-to-explore-this-december-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4020","PBYI","ITRN","SD","BK4213","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593455668","title":"Puma Biotechnology Added to Nasdaq Biotechnology Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455668","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593455668?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:29","pubTimestamp":1766442580,"startTime":"0","endTime":"0","summary":"Puma Biotechnology (PBYI) said late Monday it has been added to the Nasdaq Biotechnology Index, effective at the close of trading on Dec. 19.Shares were over 1% higher in extended trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","PBYI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593586124","title":"Puma Biotechnology Joins Nasdaq Biotechnology Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2593586124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593586124?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:10","pubTimestamp":1766437812,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. will be added to the Nasdaq Biotechnology Index  effective at the close of trading on December 19, 2025. The company’s inclusion recognizes its continued commercial execution, profitability, and clinical progress.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLcdn1XX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588061649","title":"Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588061649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588061649?lang=en_us&edition=fundamental","pubTime":"2025-12-03 06:15","pubTimestamp":1764713700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA54H07G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBYI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pumabiotechnology.com","stockEarnings":[{"period":"1week","weight":0.0679},{"period":"1month","weight":0.053},{"period":"3month","weight":0.1361},{"period":"6month","weight":0.3177},{"period":"1year","weight":1.3072},{"period":"ytd","weight":0.1361}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0454},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0209},{"period":"1year","weight":0.168},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.008257},{"month":2,"riseRate":0.5,"avgChangeRate":0.055388},{"month":3,"riseRate":0.5,"avgChangeRate":0.001561},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.047436},{"month":5,"riseRate":0.692308,"avgChangeRate":0.050713},{"month":6,"riseRate":0.538462,"avgChangeRate":-0.014244},{"month":7,"riseRate":0.538462,"avgChangeRate":0.191575},{"month":8,"riseRate":0.538462,"avgChangeRate":0.046611},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.010996},{"month":10,"riseRate":0.307692,"avgChangeRate":-0.121353},{"month":11,"riseRate":0.5,"avgChangeRate":0.134879},{"month":12,"riseRate":0.285714,"avgChangeRate":0.023235}],"exchange":"NASDAQ","name":"Puma Biotechnology","nameEN":"Puma Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Puma Biotechnology(PBYI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Puma Biotechnology(PBYI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Puma Biotechnology,PBYI,Puma Biotechnology股票,Puma Biotechnology股票老虎,Puma Biotechnology股票老虎国际,Puma Biotechnology行情,Puma Biotechnology股票行情,Puma Biotechnology股价,Puma Biotechnology股市,Puma Biotechnology股票价格,Puma Biotechnology股票交易,Puma Biotechnology股票购买,Puma Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Puma Biotechnology(PBYI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Puma Biotechnology(PBYI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction